159 related articles for article (PubMed ID: 2786708)
1. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide in patients with endocrine tumors.
Takami H; Shikata J; Kakudo K; Ito K
J Surg Oncol; 1990 Jan; 43(1):28-32. PubMed ID: 2296192
[TBL] [Abstract][Full Text] [Related]
3. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
Takami H; Ito K
Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
[TBL] [Abstract][Full Text] [Related]
5. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of plasma calcitonin gene-related peptide (CGRP) level in patients with thyroid disease].
Takami H; Shikata J; Ozaki O; Mimura T; Ito K
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):401-6. PubMed ID: 2359396
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay for calcitonin gene-related peptide and its measurement in sera of patients with thyroid disease.
Yoshida H; Hamada N; Noh J; Ito K; Morii H
Endocrinol Jpn; 1992 Feb; 39(1):81-91. PubMed ID: 1376685
[TBL] [Abstract][Full Text] [Related]
8. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
Schifter S
Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
[TBL] [Abstract][Full Text] [Related]
10. PDN-21: possible tumor marker for medullary thyroid carcinoma.
Takami H; Shikata J; Horie H; Sekine K; Ito K
J Surg Oncol; 1990 Aug; 44(4):205-7. PubMed ID: 2385096
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma.
Schifter S; Williams ED; Craig RK; Hansen HH
Clin Endocrinol (Oxf); 1986 Dec; 25(6):703-10. PubMed ID: 3308183
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin levels by ECLIA correlate well with RIA values in higher range but are affected by sex, TgAb, and renal function in lower range.
Ito Y; Kaneko H; Sasaki Y; Ohana N; Ichijo M; Furuya F; Suzuki S; Suzuki S; Shimura H
Endocr J; 2020 Jul; 67(7):759-770. PubMed ID: 32269183
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene peptides: the diagnostic value of measurement in medullary thyroid carcinoma.
Girgis SI; Lynch C; Hillyard CJ; Stevenson JC; Hill PA; MacDonald DW; MacIntyre I
Henry Ford Hosp Med J; 1987; 35(2-3):118-9. PubMed ID: 3500936
[No Abstract] [Full Text] [Related]
14. Calcitonin gene-related peptide: possible tumor marker for medullary thyroid cancer.
Poston GJ; Seitz PK; Townsend CM; Alexander RW; Rajaraman S; Cooper CW; Thompson JC
Surgery; 1987 Dec; 102(6):1049-54. PubMed ID: 3500524
[TBL] [Abstract][Full Text] [Related]
15. Identification of calcitonin and calcitonin gene-related peptide messenger ribonucleic acid in medullary thyroid carcinomas by hybridization histochemistry.
Zajac JD; Penschow J; Mason T; Tregear G; Coghlan J; Martin TJ
J Clin Endocrinol Metab; 1986 May; 62(5):1037-43. PubMed ID: 3485648
[TBL] [Abstract][Full Text] [Related]
16. Measurement of serum PDN-21 (Katacalcin) levels by radioimmunoassay in patients with various thyroid diseases.
Takami H
Exp Clin Endocrinol; 1994; 102(5):370-3. PubMed ID: 7867699
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide-like immunoreactivities in pheochromocytomas.
Mouri T; Takahashi K; Sone M; Murakami O; Ohneda M; Itoi K; Imai Y; Yoshinaga K; Sasano N
Peptides; 1989; 10(1):201-4. PubMed ID: 2787502
[TBL] [Abstract][Full Text] [Related]
18. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
20. Development and performance of a highly sensitive carboxyl-terminal-specific radioimmunoassay of calcitonin gene-related peptide.
Zaidi M; Girgis SI; MacIntyre I
Clin Chem; 1988 Apr; 34(4):655-60. PubMed ID: 3258798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
